Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Post Info TOPIC: Genotype 3?


Senior Member

Status: Offline
Posts: 115
Date:
RE: Genotype 3?
Permalink  
 


The picture does get clearer...money makes the world go around! Well I know that Donald Rumsfeld has a huge stake in Gilead....would anyone trust that oily war monger? Though I'm not a communist I wish that medical drug research was done by the state for the people without profit even entering the equation. Sovaldi was developed by Pharmasset using public funds in America, all Gilead did was steal the glory & triple the price! I don't have a clue what is coming down the pike for type three's like me? But I bet it's equally prohibitively expensive?



__________________


Guru

Status: Offline
Posts: 895
Date:
Permalink  
 

Its OK having all these combos, but they are nothing if we can't access them. I wonder what I pay insurance for now!



__________________

Genotype: 3b

VL.�over 15, 000 000

Failed TX 2014: Interferon/Riba.

Cured using Sof/Dak combination.

I can eat cake again! <3 



Guru

Status: Offline
Posts: 678
Date:
Permalink  
 

I think they will stop making Sovaldi by itself, because Sovaldi is better with Ledi than Sovaldi alone.  This will make the 2'S and 3's cost more, and still for 24 weeks and still with riba/ 

This makes Gilead more money but raise's the bar on the RAV's That is totally unfair.



-- Edited by Huey on Monday 13th of October 2014 06:40:56 AM

__________________

  HCV Genotype 3a , now Psot-Tx was on S/riba. First VL was 5.8 mil on 7-5-13 then "und" at 3.8 weeks. 06/13/14 still und. off meds 3 days back on 7/29 Last pill 08/10/14 SVR+4

 



Guru

Status: Offline
Posts: 1724
Date:
Permalink  
 

Tig56 wrote:

Perhaps it's as simple as wanting the whole pie all to themselves? I'm sure Riba would offer a more affordable price structure, but Gilead doesn't care to share in the glory... This picture keeps getting clearer and clearer!

 


Wow, that is really greedy.  If they pulled Sovaldi (sold alone) from the market there would also be zero chance of Daclatasvir or any other DAA being used with it (even off label). 

 



__________________

Diagnosed in 2011, Incivek triple in 2011, tx discontinued, Genotype 1a, CT, VL 7mill, cirrhosis dx in 2012, age 67, waiting for new DAAs.

Tig


Admin

Status: Offline
Posts: 9284
Date:
Permalink  
 

Perhaps it's as simple as wanting the whole pie all to themselves? I'm sure Riba would offer a more affordable price structure, but Gilead doesn't care to share in the glory... This picture keeps getting clearer and clearer!

Tig



__________________

Tig

68yo GT1A - 5 Mil - A2/F3 - (1996) Intron A - Non Responder, (2013) Peg/Riba/Vic SOT:05/23/13 EOT:12/04/13 SVR 9+ years!

Hep C FAQ   Lab Ref. Ranges  HCV Resistance

Signature Line Set Up/Abbreviations   Payment Assistance

 



Guru

Status: Offline
Posts: 3398
Date:
Permalink  
 

Hi all,

I must admit that I'm confused about the message Gilead is sending to the Genotype 3's. In the Prescribing Information for Harvoni, it states that Ledipasvir has reduced activity against Genotypes 2 and 3.

However, the ongoing Electron2 Trial (Harvoni +/- Riba for 12 weeks), gives 100% SVR rates for geno 3 if Riba is used.

Perhaps they are holding out for their new pan-genotype NS-5A inhibitor- GS-5816.

http://www.aidsmap.com/Sofosbuvir-new-GS-5816-NS5A-inhibitor-is-effective-against-hepatitis-C-genotypes-1-6/page/2847422/

 



__________________

Geno 1b, IL28B CT,  x3 prior relapser,  ex-cirrhotic, 75 yo, did 48 weeks with Victrelis/Peg./Riba.  VL 1.28m at start, UNDET. at 8 ,12 ,16 ,24 ,30  and 48 weeks.  EOT 15 Feb 2013 , UNDET. at EOT + 28 weeks. SVR!  Still Undet. at EOT +5 years

Malcolm

Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.

Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.